Oral administration of adrafinil improves discrimination learning in aged beagle dogs. 2000

N W Milgram, and C T Siwak, and P Gruet, and P Atkinson, and F Woehrlé, and H Callahan
Division of Life Sciences, University of Toronto at Scarborough, 1265 Military Trail, M1C 1A4, Scarborough, Ontario, Canada.

Aged beagle dogs were trained on either a size or intensity discrimination task 2 h following treatment with either 20 mg/kg of adrafinil or a placebo control. Training continued until the dogs reached a predetermined criterion level of performance, or failed to acquire the task after 40 sessions. The treatments and tasks were then reversed, with both the test order and treatment order counterbalanced. Thus, half of the animals were first tested on the intensity discrimination, and half of these were first tested under adrafinil. Treatment with adrafinil produced significant improvement in learning, as indicated by a decrease in both errors and trials to criterion. An effect of adrafinil on motivation may partially account for these findings; however, adrafinil did not significantly affect response latency. Adrafinil is believed to serve as an alpha-1 adrenoceptor agonist. The improved learning may also result from enhancement of vigilance due to facilitation of noradrenergic transmission in the central nervous system.

UI MeSH Term Description Entries
D008297 Male Males
D009042 Motivation Those factors which cause an organism to behave or act in either a goal-seeking or satisfying manner. They may be influenced by physiological drives or by external stimuli. Incentives,Disincentives,Expectations,Disincentive,Expectation,Incentive,Motivations
D004193 Discrimination Learning Learning that is manifested in the ability to respond differentially to various stimuli. Discriminative Learning,Discrimination Learnings,Discriminative Learnings,Learning, Discrimination,Learning, Discriminative
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006877 Hydroxamic Acids A class of weak acids with the general formula R-CONHOH. Hydroxamic Acid,Acid, Hydroxamic,Acids, Hydroxamic
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000316 Adrenergic alpha-Agonists Drugs that selectively bind to and activate alpha adrenergic receptors. Adrenergic alpha-Receptor Agonists,alpha-Adrenergic Receptor Agonists,Adrenergic alpha-Agonist,Adrenergic alpha-Receptor Agonist,Receptor Agonists, Adrenergic alpha,Receptor Agonists, alpha-Adrenergic,alpha-Adrenergic Agonist,alpha-Adrenergic Agonists,alpha-Adrenergic Receptor Agonist,Adrenergic alpha Agonist,Adrenergic alpha Agonists,Adrenergic alpha Receptor Agonist,Adrenergic alpha Receptor Agonists,Agonist, Adrenergic alpha-Receptor,Agonist, alpha-Adrenergic,Agonist, alpha-Adrenergic Receptor,Agonists, Adrenergic alpha-Receptor,Agonists, alpha-Adrenergic,Agonists, alpha-Adrenergic Receptor,Receptor Agonist, alpha-Adrenergic,Receptor Agonists, alpha Adrenergic,alpha Adrenergic Agonist,alpha Adrenergic Agonists,alpha Adrenergic Receptor Agonist,alpha Adrenergic Receptor Agonists,alpha-Agonist, Adrenergic,alpha-Agonists, Adrenergic,alpha-Receptor Agonist, Adrenergic,alpha-Receptor Agonists, Adrenergic
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central

Related Publications

N W Milgram, and C T Siwak, and P Gruet, and P Atkinson, and F Woehrlé, and H Callahan
November 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
N W Milgram, and C T Siwak, and P Gruet, and P Atkinson, and F Woehrlé, and H Callahan
January 1988, Neurobiology of aging,
N W Milgram, and C T Siwak, and P Gruet, and P Atkinson, and F Woehrlé, and H Callahan
June 1982, Chemical & pharmaceutical bulletin,
N W Milgram, and C T Siwak, and P Gruet, and P Atkinson, and F Woehrlé, and H Callahan
January 1980, Journal of environmental pathology and toxicology,
N W Milgram, and C T Siwak, and P Gruet, and P Atkinson, and F Woehrlé, and H Callahan
December 2022, Veterinary dermatology,
N W Milgram, and C T Siwak, and P Gruet, and P Atkinson, and F Woehrlé, and H Callahan
January 2011, Journal of Alzheimer's disease : JAD,
N W Milgram, and C T Siwak, and P Gruet, and P Atkinson, and F Woehrlé, and H Callahan
March 1993, Biological & pharmaceutical bulletin,
N W Milgram, and C T Siwak, and P Gruet, and P Atkinson, and F Woehrlé, and H Callahan
May 2008, International journal of pharmaceutics,
N W Milgram, and C T Siwak, and P Gruet, and P Atkinson, and F Woehrlé, and H Callahan
May 1997, Journal of pharmaceutical sciences,
N W Milgram, and C T Siwak, and P Gruet, and P Atkinson, and F Woehrlé, and H Callahan
September 2020, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!